✦ LIBER ✦

Outcome of Tandem Autologous/Allogeneic Hematopoietic Cell Transplantation in High-Risk Non Hodgkin's Lymphoma Patients: Stanford University Experience

✍ Scribed by Wudhikarn, Kitsada; Lavori, Philip; Arai, Sally; Johnston, Laura; Laport, Ginna G.; Lowsky, Robert; Miklos, David B.; Shizuru, Judith A.; Hoppe, Richard T.; Benjamin, Jonathan; Meyer, Everett; Negrin, Robert; Weng, Wen-Kai

Book ID: 122333702
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 53 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.12.262

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of rituximab in autologous and

The role of rituximab in autologous and allogeneic hematopoietic stem cell transplantation for non-Hodgkin’s lymphoma

✍ Elizabeth Naparstek 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 158 KB

Allogeneic Hematopoietic Cell Transplant

Allogeneic Hematopoietic Cell Transplant (Allo-HCT) for Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma: The University of Michigan Experience

✍ Pawarode, Attaphol; Braun, Thomas; Magenau, John; Choi, Sung Won; Kitko, Carrie 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Long Term Outcomes of Autologous Hematop

Long Term Outcomes of Autologous Hematopoietic Cell Transplant (AHCT) Following Thiotepa-Based High-Dose Therapy (HDT) in Patients with Non-Hodgkin Lymphoma (NHL)

✍ Shah, Nilay A.; Rauenzahn, Sherri; Wen, Sijin; Craig, Michael; Kanate, Abraham S 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Myeloablative vs non-myeloablative condi

Myeloablative vs non-myeloablative conditioning with allogeneic stem cell transplantation for high risk non-Hodgkin’s lymphoma: Similar outcomes despite differences in disease risk

✍ M. Hewitt; D.L. Porter; K. Hummel; A. McAlee; J. Phillips; E. Stadtmauer; S. Sch 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Virus reactivation in high-risk non-Hodg

Virus reactivation in high-risk non-Hodgkin’s lymphoma patients after autologous CD34+-selected peripheral blood progenitor cell transplantation

✍ Peng-Chan Lin; Ming-Yang Lee; Jen-Tsun Lin; Liang-Tsai Hsiao; Po-Min Chen; Tzeon 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 175 KB

P009 “High-risk” patients with aggressiv

P009 “High-risk” patients with aggressive non-Hodgkin lymphoma should benefit from autologous stem cell transplantation in first remission (single-centre experience)

✍ S. Genadieva Stavrik; L. Cevreska; Z. Stojanoski; A. Pivkova; A. Stojanovik; S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB